48 Stocks Moving In Friday's Mid-Day Session

Gainers

• Belite Bio Inc. ADR BLTE shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS.
• GTY Technology Holdings Inc. GTYH shares jumped 116.3% to $6.12 as the company agreed to be acquired by GI Partners.
• Vaxxinity, Inc. VAXX surged 63.3% to $6.17. Vaxxinity Executive chairman Lou Reese purchased 22,912 shares at $3.48 per share.
• Zymeworks Inc. ZYME shares climbed 32% to $6.55. Zymeworks confirmed it received an unsolicited, non-binding proposal from All Blue Falcons FZE and its affiliates to purchase the company for $10.50 per share. The Zymeworks board of directors will carefully review the proposal.
• Finch Therapeutics Group, Inc. FNCH gained 29.5% to $2.72. The FDA has removed the clinical hold on Finch Therapeutics Group’s investigational new drug application for CP101, an orally administered microbiome therapeutic, which is in Phase 3 study for recurrent C. difficile infection.
• Opiant Pharmaceuticals, Inc. OPNT jumped 29.2% to $23.79. Opiant Pharmaceuticals and Hikma Earlier reported exclusive $225 million commercialization and license agreement for OPNT003, Nasal Nalmefene, in Europe and UK.
• Redbox Entertainment Inc. RDBX jumped 28% to $4.5300.
• Clearwater Paper Corporation CLW gained 22.7% to $33.69 after the company reported better-than-expected Q1 EPS and sales results.
• Anixa Biosciences, Inc. ANIX jumped 21% to $3.29.
• Pinduoduo Inc. PDD rose 18.4% to $44.92 after a Chinese state media report indicated the Chinese government may end its regulatory crackdown on big tech firms.
• Bioceres Crop Solutions Corp. BIOX gained 17.5% to $14.06. China approved the HB4 strain of soy developed by Bioceres.
• Cyngn Inc. CYN gained 17.2% to $4.6070. Cyngn priced its 6.45 million share offering at $3.10 per unit.
• Full Truck Alliance Co. Ltd. YMM rose 17.1% to $5.86 on hopes Chinese regulators will ease its crackdown on tech and internet companies. Strength comes ahead of an expected joint regulatory meeting, which reportedly could occur this weekend.
• Hello Group Inc. MOMO gained 16.6% to $5.28.
• Bilibili Inc. BILI rose 16.1% to $25.73 on hopes Chinese regulators will ease its crackdown on tech and internet companies. Strength comes ahead of an expected joint regulatory meeting, which reportedly could occur this weekend.
• Kanzhun Limited BZ gained 15.3% to $24.03
• ATRenew Inc. RERE gained 14.8% to $3.01.
• iQIYI, Inc. IQ shares rose 12.6% to $3.76 on hopes Chinese regulators will ease its crackdown on tech and internet companies. Strength comes ahead of an expected joint regulatory meeting, which reportedly could occur this weekend.
• NCR Corporation NCR gained 11.7% to $35.62.
• Alibaba Group Holding Limited BABA rose 11.2% to $101.07. Analysts slashed the earnings estimates for the Chinese technology giants for a second straight month amid the nation’s persistent goal of its Covid-Zero strategy, Bloomberg reported. Analysts trimmed Alibaba Group estimates by 4.2%.
• Cytokinetics, Incorporated CYTK gained 11.1% to $39.72. HC Wainwright & Co. maintained Cytokinetics with a Buy and raised the price target from $69 to $75.
• KE Holdings Inc. BEKE rose 10.1% to $14.66.
• Trip.com Group Limited TCOM jumped 9.9% to $24.49.
• JD.com, Inc. JD gained 9.6% to $63.37 after a Chinese state media report indicated the Chinese government may end its regulatory crackdown on big tech firms.
• DiDi Global Inc. DIDI rose 9.1% to $1.9750 on hopes Chinese regulators will ease its crackdown on tech and internet companies. Strength comes ahead of an expected joint regulatory meeting, which reportedly could occur this weekend.
• Innate Pharma S.A. IPHA rose 8.5% to $2.93. Innate Pharma announced that AstraZeneca has started dosing in its Phase 3 trial, PACIFIC-9, evaluating durvalumab (PD-L1) combined with monalizumab (NKG2A) or AstraZeneca's oleclumab (anti-CD73) in non-small cell lung cancer.
• Kingsoft Cloud Holdings Limited KC rose 7.3% to $3.99 on hopes Chinese regulators will ease its crackdown on tech and internet companies. Strength comes ahead of an expected joint regulatory meeting, which reportedly could occur this weekend.
• GDS Holdings Limited GDS rose 6.3% to $31.50. GDS Holdings filed its annual report on Form 20-F for the fiscal year ended December 31, 2021.

Losers

• Accolade, Inc. ACCD shares tumbled 47.4% to $5.82 after the company reported Q4 earnings results and issued Q1 sales guidance below analyst estimates.
• Genocea Biosciences, Inc. GNCA fell 24% to $0.31 after the company announced that it has initiated a process to explore a range of strategic alternatives including the sale of all or part of the company, a merger or a reverse merger.
• LianBio LIAN fell 23.7% to $3.83. LianBio highlighted that its partner, Bristol Myers, announced the FDA approval for Camzyos.
• CooTek (Cayman) Inc. CTK fell 22.4% to $0.17 after the company announced a plan to implement a 1-to-650 ADS ratio change.
• IES Holdings, Inc. IESC dipped 19.4% to $28.45 after the company posted a loss for its second quarter.
• Sono Group N.V. SEV dropped 19% to $3.86.
• T Stamp Inc. IDAI fell 18.1% to $3.85. T Stamp shares jumped around 124% on Thursday after the company announced the launch of its Biometric MFA solution.
• Statera Biopharma, Inc. STAB shares fell 17.9% to $0.3120. Statera Biopharma shares jumped over 80% on Thursday after the company and Immune Therapeutics announced a strategic agreement for rights to low dose naltrexone.
• Cooper-Standard Holdings Inc. CPS dropped 16.3% to $4.98
• Aldeyra Therapeutics, Inc. ALDX fell 16.2% to $3.0585. Aldeyra Therapeutics CFO and Treasurer Joshua Reed tendered his resignation to pursue other career opportunities.
• Tuniu Corporation TOUR fell 16% to $0.65 after jumping 22% on Thursday.
• Mitek Systems, Inc. MITK dipped 15.2% to $11.02 following Q2 results.
• Evoke Pharma, Inc. EVOK shares fell 15% to $0.4231 after dipping 25% on Thursday.
• B. Riley Financial, Inc. RILY dropped 13.2% to $46.56 following Q1 results.
• Century Aluminum Company CENX fell 12.8% to $16.85 after reporting Q1 results.
• VeriSign, Inc. VRSN fell 12.6% to $182.00 following Q1 results.
• Amazon.com, Inc. AMZN shares fell 12.5% to $2,530.50. Amazon reported a $3.8 billion net loss for the first quarter, versus a year-ago net income of $8.1 billion. The company also issued weak Q2 sales guidance.
• The Western Union Company WU dropped 11.1% to $17.03 after the company reported worse-than-expected Q1 sales results and cut guidance.
• AbbVie Inc. ABBV fell 8.8% to $142.53 after the company reported worse-than-expected Q1 sales results and updated guidance.
• Ra Medical Systems, Inc. RMED fell 7.6% to $0.3452 after jumping 26% on Thursday.